The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Clorox shares hit a 52-week low of $96.36, extending a monthly decline of 5.8% as analysts turn increasingly bearish on revenue estimates. The company is scheduled to report its Q1 earnings this Thursday, with market consensus pointing toward flat year-on-year revenue growth. This follows a previous earnings miss where EPS came in at $1.39 against the $1.43 expected, alongside a 0.8% revenue contraction. Additionally, International Paper is set to release its Q1 results this Thursday, with expectations also centered on stagnant annual revenue. Analysts currently maintain a 'Reduce' rating on Clorox, reflecting concerns over its organic growth trajectory and persistent sector headwinds. Investors remain cautious ahead of the upcoming financial disclosures to see if the company can stabilize its bottom-line performance.
Sign in to access this content
Sign In